Академический Документы
Профессиональный Документы
Культура Документы
D
Department of Pharmaceutics KLE Universitys College of Pharmacy BELGAUm 590010, Karnataka, India Cell No: 00919742431000 E-mail: bknanjwade@yahoo.co.in
08/10/2010 KLECOP, Nipani 1
CONTENTS
Introduction of absorption. Structure of the Cell Membrane. Gastro intestinal absorption of drugs. Mechanism of Drug absorption. Factors affecting drug absorption Absorption of drugs from non-per oral routes Methods of determining absorption References.
KLECOP, Nipani 2
08/10/2010
Introduction of Absorption
Definition : The process of movement of unchanged drug from the site of administration to systemic circulation.
There always exist a correlation between the plasma concentration of a drug & the therapeutic response & thus, absorption can also be defined as the process of movement of unchanged drug from the site of administration to the site of measurement. i.e., plasma.
KLECOP, Nipani 3
08/10/2010
Therapeutic success of a rapidly & completely absorbed drug. Plasma Drug Minimum effective conc. Therapeutic failure of a slowly absorbed drug. Subtherapeutic level
Conc.
Not only the magnitude of drug that comes into the systemic circulation but also the rate at which it is absorbed is important this is clear from the figure.
Time
08/10/2010
KLECOP, Nipani
08/10/2010
KLECOP, Nipani
CELL MEMBRANE
Also called the plasma membrane, plasmalemma or phospholipid bilayer. The plasma membrane is a flexible yet sturdy barrier that surrounds & contains the cytoplasm of a cell. Cell membrane mainly consists of: 1. Lipid bilayer-phospholipid -Cholesterol -Glycolipids. 2. Proitens-Integral membrane proteins -Lipid anchored proteins -Peripheral Proteins
KLECOP, Nipani 6
08/10/2010
LIPID BILAYER
08/10/2010
KLECOP, Nipani
LIPID BILAYER
The basic structural framework of the plasma membrane is the lipid bilayer. Consists primarily of a thin layer of amphipathic phospholipids which spontaneously arrange so that the hydrophobic tail regions are shielded from the surrounding polar fluid, causing the more hydrophilic head regions to associate with the cytosolic & extracellular faces of the resulting bilayer. This forms a continuous, spherical lipid bilayer app. 7nm thick.
KLECOP, Nipani 8
08/10/2010
It consists of two back to back layers made up of three types: Phospholipid, Cholesterol, Glycolipids. 1) Phospholipids :
Principal type of lipid in membrane about 75 %. Contains polar and non polar region. Polar region is hydrophilic and non polar region is hydrophobic. Non polar head contain two fatty acid chain. One chain is straight fatty acid chain.( Saturated ) Another tail have cis double bond and have kink in tail. ( Unsaturated )
08/10/2010 KLECOP, Nipani 9
CHOLESTEROL
Amount in membrane is 20 %. Insert in membrane with same orientation as phospholipids molecules. Polar head of cholesterol is aligned with polar head of phospholipids.
FUNCTION: Immobilize first few hydrocarbons groups phospholipids molecules. Prevents crystallization of hydrocarbons & phase shift in membrane
08/10/2010 KLECOP, Nipani 10
OH
08/10/2010
KLECOP, Nipani
11
08/10/2010
KLECOP, Nipani
12
GLYCOLIPIDS
Another component of membrane lipids present about 5 %. Carbohydrate groups form polar head. Fatty acids tails are non polar. Present in membrane layer that faces the extracellular fluid. This is one reason due to which bilayer is asymmetric. FUNCTIONS: Protective Insulator Site of receptor binding
KLECOP, Nipani 13
08/10/2010
08/10/2010
KLECOP, Nipani
14
COMPOSITION OF PROTEINS
PROTEINS
INTEGRAL PROTEINS
PERIPHERAL PROTEINS
08/10/2010
15
INTEGRAL PROTEINS
Also known as Transmembrane protein. Have hydrophilic and hydrophobic domain. Hydrophobic domain anchore within the cell membrane and hydrophilic domain interacts with external molecules. Hydrophobic domain consists of one, multiple or combination of helices and sheets protein mofits. Ex. Ion Channels, Proton pump, GPCR.
KLECOP, Nipani 16
08/10/2010
Covalently bound to single or multiple lipid molecules. Hydrophobically inert into cell membrane & anchor the protein. The protein itself is not in contact with membrane. Ex. G Proteins.
KLECOP, Nipani 17
08/10/2010
PERIPHERAL PROTEINS
Attached to integral membrane proteins OR associated with peripheral regions of lipid bilayer. Have only temporary interaction with biological membrane. Once reacted with molecule, dissociates to carry on its work in cytoplasm. Ex. Some Enzyme, Some Hormone
KLECOP, Nipani 18
08/10/2010
08/10/2010
KLECOP, Nipani
19
Stomach :
The surface area for absorption of drugs is relatively small in the stomach due to the absence of macrovilli & microvilli. Extent of drug absorption is affected by variation in the time it takes the stomach to empty, i.e., how long the dosage form is able to reside in stomach. Drugs which are acid labile must not be in contact with the acidic environment of the stomach. Stomach emptying applies more to the solid dosage forms because the drug has to dissolve in the GI fluid before it is available for absorption. Since solubility & dissolution rate of most drugs is a function of pH, it follows that, a delivery system carrying a drug that is predominantly absorbed from the stomach, must stay in the stomach for an extended period of time in order to assure maximum dissolution & therefore to extent of absorption.
08/10/2010
KLECOP, Nipani
20
Small Intestine :
The drugs which are predominantly absorbed through the small intestine, the transit time of a dosage form is the major determinant of extent of absorption. Various studies to determine transit time: Early studies using indirect methods placed the average normal transit time through the small intestine at about 7 hours. These studies were based on the detection of hydrogen after an oral dose of lactulose. (Fermentation of lactulose by colon bacteria yields hydrogen in the breath).
08/10/2010
KLECOP, Nipani
21
08/10/2010
Large intestine :
The major function of large intestine is to absorb water from ingestible food residues which are delivered to the large intestine in a fluid state, & eliminate them from the body as semi solid feces.
Only a few drugs are absorbed in this region.
08/10/2010
KLECOP, Nipani
23
1) PASSIVE DIFFUSION
Also known as non-ionic diffusion. It is defined as the difference in the drug concentration on either side of the membrane. Absorption of 90% of drugs. The driving force for this process is the concentration or electrochemical gradient.
25
08/10/2010
KLECOP, Nipani
Passive diffusion is best expressed by Ficks first law of diffusion which states that the drug molecules diffuse from a region of higher concentration to one of lower concentration until equilibrium is attained & the rate of diffusion is directly proportional to the concentration gradient across the membrane. dQ dt
=
D A Km/w h
(CGIT C)
b) Greater the surface area & lesser the thickness of the membrane, faster the diffusion. c) Equilibrium is attained when the concentration on either side of the membrane become equal. d) Greater the membrane/ water partition coefficient of drug, faster the absorption. Passive diffusion process is energy independent but depends more or less on the square root of the molecular size of the drugs. The mol. Wt. of the most drugs lie between 100 to 400 Daltons which can be effectively absorbed passively.
08/10/2010 KLECOP, Nipani 27
2) Pore transport
Also known as convective transport, bulk flow or filtration. Important in the absorption of low mol. Wt. (less than 100). Low molecular size (smaller than the diameter of the pore) & generally water-soluble drugs through narrow, aqueous filled channels or pores in the membrane structure. e.g. urea, water & sugars. The driving force for the passage of the drugs is the hydrostatic or the osmotic pressure difference across the membrane.
The rate of absorption via pore transport depends on the number & size of the pores, & given as follows: dc dt
=
N. R2. A . C () (h)
where, dc = dt N = R = C = =
08/10/2010
Involves a carrier (a component of the membrane) which binds reversibly with the solute molecules to be transported to yield the carrier solute complex which transverses across the membrane to the other side where it dissociates to yield the solute molecule The carrier then returns to its original site to accept a fresh molecule of solute. There are two types of carrier mediated transport system: a) facilitated diffusion b) active transport
KLECOP, Nipani 30
08/10/2010
a) Facilitated diffusion
This mechanism involves the driving force is concentration gradient. In this system, no expenditure of energy is involved (down-hill transport), therefore the process is not inhibited by metabolic poisons that interfere with energy production.
31
08/10/2010
KLECOP, Nipani
Limited importance in the absorption of drugs. e.g. Such a transport system include entry of glucose into RBCs & intestinal absorption of vitamins B1 & B2. A classical example of passive facilitated diffusion is the gastro-intestinal absorption of vitamin B12. An intrinsic factor (IF), a glycoprotein produced by the gastric parietal cells, forms a complex with vitamin B12 which is then transported across the intestinal membrane by a carrier system.
08/10/2010
KLECOP, Nipani
32
b) Active transport
More important process than facilitated diffusion. The driving force is against the concentration gradient or uphill transport. Since the process is uphill, energy is required in the work done by the barrier. As the process requires expenditure of energy, it can be inhibited by metabolic poisons that interfere with energy production.
33
08/10/2010
KLECOP, Nipani
If drugs (especially used in cancer) have structural similarities to such agents, they are absorbed actively. A good example of competitive inhibition of drug absorption via active transport is the impaired absorption of levodopa when ingested with meals rich in proteins. The rate of absorption by active transport can be determined by applying the equation used for Michalies-menten kinetics: dc = [C].(dc/dt)max dt Km + [C]
(dc/dt)max = maximal rate of drug absorption at high drug concentration. [C] = concentration of drug available for absorption Km = affinity constant of drug for the barrier.
08/10/2010 KLECOP, Nipani 34
Where,
This charge influences the permeation of drugs. Molecular forms of solutes are unaffected by the membrane charge & permeate faster than ionic forms. The permeation of anions & cations is also influenced by pH. Thus, at a given pH, the rate of permeation may be as follows: Unionized molecule > anions > cations
08/10/2010
KLECOP, Nipani
35
The permeation of ionized drugs, particularly the cationic drugs, depend on the potential difference or electrical gradient as the driving force across the membrane. Once inside the membrane, the cations are attached to negatively charged intracellular membrane, thus giving rise to an electrical gradient. If the same drug is moving from a higher to lower concentration, i.e., moving down the electrical gradient , the phenomenon is known as electrochemical diffusion.
KLECOP, Nipani 36
08/10/2010
It is another mechanism is able to explain the absorption of such drugs which ionize at all pH condition.
08/10/2010
KLECOP, Nipani
37
Transport of charged molecules due to the formation of a neutral complex with another charged molecule carrying an opposite charge. Drugs have low o/w partition coefficient values, yet these penetrate the membrane by forming reversible neutral complexes with endogenous ions. e.g. mucin of GIT. Such neutral complexes have both the required lipophilicity as well as aqueous solubility for passive diffusion. This phenomenon is known as ion-pair transport.
KLECOP, Nipani 38
08/10/2010
6) ENDOCYTOSIS
It involves engulfing extracellular materials within a segment of the cell membrane to form a saccule or a vesicle (hence also called as corpuscular or vesicular transport) which is then pinched off intracellularly.
39
08/10/2010
KLECOP, Nipani
A)
B)
C)
Pinocytosis
Transcytosis
08/10/2010
KLECOP, Nipani
40
A) Phagocytosis
08/10/2010
KLECOP, Nipani
41
B) Pinocytosis
This process is important in the absorption of oil soluble vitamins & in the uptake of nutrients.
08/10/2010
KLECOP, Nipani
42
C) Transcytosis
It is a phenomenon in which endocytic vesicle is transferred from one extracellular compartment to another.
08/10/2010
KLECOP, Nipani
43
Rate dependent on polarity and size. Polarity estimated using the partition coefficient.
The greater the lipid solubility the faster the rate of diffusion
Smaller molecules (nm/A0) penetrate more rapidly. Highly permeable to O2, CO2, NO and H2O .
08/10/2010
KLECOP, Nipani
45
08/10/2010
KLECOP, Nipani
46
BIOLOGICAL FACTORS:
Penetration Of Drugs Through Gastro-intestinal Tract Penetration Of Drugs Through Blood Brain Barrier Penetration Of Drugs Through Placental Barrier Penetration Of Drugs Through Across The Skin Penetration Of Drugs Through The Mucous Membrane Of The Nose, Throat, Trachea, Buccal Cavity, Lungs ,Vaginal And Rectal Surfaces
PHYSIOLOGICAL FACTORS:
Gastrointestinal (Gi) Physiology Influence Of Drug Pka And Gi Ph On Drug Absorbtion Git Blood Flow Gastric Emptying Disease States
KLECOP, Nipani 47
08/10/2010
1. PASSIVE DIFFUSION
Major process for absorption of more than 90% of drugs Diffusion follows Ficks law: The drug molecules diffuse from a region of higher concentration to a region of lower concentration till equilibrium is attained. Rate of diffusion is directly proportional to the concentration gradient across the membrane. Factors affecting Passive diffusion: Diffusion coefficient of the drug Related to lipid solubility and molecular wt. Thickness and surface area of the membrane Size of the molecule
KLECOP, Nipani 49
08/10/2010
08/10/2010
KLECOP, Nipani
50
2. PORE TRANSPORT
It involves the passage of ions through Aq. Pores (4-40 A0) Low molecular weight molecules (less than 100 Daltons) eg- urea, water, sugar are absorbed. Also imp. In renal excretion, removal of drug from CSF and entry of drugs into liver.
08/10/2010
KLECOP, Nipani
51
3. FACILITATED DIFFUSION
Carrier mediated transport (downhill transport) Faster than passive diffusion No energy expenditure is involved Not inhibited by metabolic poisons Important in transport of Polar molecules and charged ions that dissolve in water but they can not diffuse freely across cell membranes due to the hydrophobic nature of the phospholipids.
Eg. 1. entry of glucose into RBCs 2. intestinal absorption vitamin B1 ,B2 3. transport of amino acids thru permeases
08/10/2010 KLECOP, Nipani 52
08/10/2010
KLECOP, Nipani
53
4. ACTIVE TRANSPORT
Carrier mediated transport (uphill transport) Energy is required in the work done by the carrier Inhibited by metabolic poisons Endogenous substances that are transported actively include sodium, potassium, calcium, iron, glucose, amino acids and vitamins like niacin, pyridoxin. Drugs having structural similarity to such agents are absorbed actively Eg. 1. Pyrimidine transport system absorption of 5 FU and 5 BU 2. L-amino acid transport system absorption of methyldopa and levodopa
KLECOP, Nipani 54
08/10/2010
08/10/2010
KLECOP, Nipani
55
5. PINOCYTOSIS
Pinocytosis ("cell-drinking")
Uptake of fluid solute. A form of endocytosis in which small particles are brought into the cell in the form of small vesicles which subsequently fuse with lysosomes to hydrolyze, or to break down, the particles. This process requires energy in the form of (ATP). Polio vaccine and large protein molecules are absorbed by pinocytosis
KLECOP, Nipani 56
08/10/2010
08/10/2010
KLECOP, Nipani
57
A stealth of endothelial cells lining the capillaries. It has tight junctions and lack large intra cellular pores. Further, neural tissue covers the capillaries. Together , they constitute the so called BARRIER BLOOD BRAIN
Astrocytes : Special cells / elements of supporting tissue found at the base of endothelial membrane. The blood-brain barrier (BBB) is a separation of circulating blood and cerebrospinal fluid (CSF) maintained by the choroid plexus in the central nervous system (CNS).
KLECOP, Nipani 58
08/10/2010
08/10/2010
KLECOP, Nipani
59
Endothelial cells restrict the diffusion of microscopic objects (e.g. bacteria ) and large or hydrophillic molecules into the CSF, while allowing the diffusion of small hydrophobic molecules (O2, hormones, CO2). Cells of the barrier actively transport metabolic products such as glucose across the barrier with specific proteins.
Use of Permeation enhancers such as dimethyl sulfoxide (DMSO) Osmotic disruption of the BBB by infusing internal carotid artery with mannitol Use of Dihydropyridine redox system as drug carriers to the brain ( the lipid soluble dihydropyridine is linked as a carrier to the polar drug to form a prodrug that rapidly crosses the BBB )
KLECOP, Nipani 60
08/10/2010
Placenta is the membrane separating fetal blood from the maternal blood. It is made up of fetal trophoblast basement membrane and the endothelium. Mean thickness (25 ) in early pregnancy and reduces to (2 ) at full term Many drugs having mol. wt. < 1000 daltons and moderate to high lipid solubility e.g. ethanol, sulfonamides , barbiturates, steroids , anticonvulsants and some antibiotics cross the barrier by simple diffusion quite rapidly . Nutrients essential for fetal growth are transported by carrier mediated processes
KLECOP, Nipani 61
08/10/2010
08/10/2010
KLECOP, Nipani
62
Skin is composed of three primary layers: the epidermis , which provides waterproofing and serves as a barrier to infection; the dermis , which serves as a location for the appendages of skin; and the hypodermis (subcutaneous adipose layer). The stratum corneum is the outermost layer of the epidermis and is composed mainly of dead keratinised cells (from lack of oxygen and nutrients). It has a thickness between 10 - 40 m. The dermis is the layer of skin beneath the epidermis. It contains the hair follicles, sweat glands, sebaceous glands, apocrine glands, lymphatic vessels and blood vessels. Hypodermis - Its purpose is to attach the skin to underlying bone and muscle as well as supplying it with blood vessels and nerves. The main cell types are fibroblasts, macrophages and adipocytes (the hypodermis contains 50% of body fat).
08/10/2010
KLECOP, Nipani
63
08/10/2010
KLECOP, Nipani
64
ROUTES OF PENETRATION
Through follicular region Through sweat ducts Through unbroken stratum corneum
2.
3.
4.
Thickness of the skin layer: (Thickest on palms and soles & thinest on the face) Skin condition: permeability of skin is affected by age, disease state or injury. Skin temp.: permeability increases with increase in temp. Hydration state
08/10/2010
Penetration Of Drugs Through The Mucous Membrane Of The Nose, Throat, Trachea, Buccal Cavity, Lungs ,Vaginal And Rectal Surfaces
The barrier for the drug absorption is the capillary endothelial membrane which is lipoidal and consists of pores . Thus, lipid soluble drugs can easily penetrate by diffusion and smaller drug molecules can penetrate by pore transport.
08/10/2010
KLECOP, Nipani
66
Membrane
thin
Blood Supply
Good, fast absorption with low dose -
Surface Area
small
Transit Time
Short unless controlled
By-pass liver
yes
ESOPHAGUS
small
short
STOMACH
13
good
small
no
DUODENUM
57
good
large
no
6 -7
good
about 3 hours
no
6.8 - 7
good
08/10/2010
KLECOP, Nipani
67
SMALL INTESTINE :
Major site for absorption of most drugs due to its large surface area (0.33 m2 ). It is 7 meters in length and is approximately 2.5-3 cm in diameter. The Folds in small intestine called as folds of kerckring, result in 3 fold increase in surface area ( 1 m2). These folds possess finger like projections called Villi which increase the surface area 30 times ( 10 m2). From the surface of villi protrude several microvilli which increase the surface area 600 times ( 200 m2). Blood flow is 6-10 times that of stomach. PH Range is 57.5 , favourable for most drugs to remain unionised. Peristaltic movement is slow, while transit time is long. Permeability is high.
All these factors make intestine the best site for absorbtion of most drugs.
08/10/2010 KLECOP, Nipani 68
Strong acids (pKa <2.5) Very weak bases (pKa < 5) Moderately weak bases (pKa 5 11 )
KLECOP, Nipani
69
It plays an imp. role in drug absorption by continuously maintaining the conc. Gradient across the epithelial membrane
Polar molecules that are slowly absorbed show no dependence on blood flow The absorption of lipid soluble drugs and molecules that are small enough to easily penetrate through Aq. pores is rapid and highly dependent on rate of blood flow
08/10/2010
KLECOP, Nipani
70
GASTRIC EMPTYING
The process by which food leaves the stomach and enters the duodenum. It is a RDS in drug absorbtion. Rapid Gastric Emptying Advisable when : Rapid onset of action is desired eg. Sedatives Dissolution occurs in the intestine eg. Enteric coated tablets Drugs not stable in gi fluids eg. penicillin G Drug is best absorbed from small intestine eg. Vitamin B12
Delay in Gastric Emptying recommended when Food promotes drug dissolution and absorbtion eg. Gresiofulvin Disintegration and dissolution is is promoted by gastric fluids
KLECOP, Nipani 71
08/10/2010
Temperature of Food Increase in temperature, increase in emptying rate Body Position Git PH Emotional state Disease states Lying on the left side decreases emptying rate and right side promotes it Retarded at low stomach PH and promoted at higher alkaline PH Anxiety promotes where as depression retards it gastric ulcer, hypothyroidism retards it, while duodenal ulcer, hyperthyroidism promotes it.
KLECOP, Nipani 72
08/10/2010
DISEASE STATES
CHF decreases blood flow to the Git, alters GI PH, secretions and microbial flora. Cirrhosis influences bioavailability mainly of drugs that undergo considerable 1st pass metabolism eg. Propranolol Git infections like cholera and food poisoning also result in malabsorbtion.
08/10/2010
KLECOP, Nipani
73
PHYSIO-CHEMICAL FACTORS
PHYSICAL FACTORS PHYSIO-CHEMICAL FACTORS
08/10/2010
KLECOP, Nipani
74
PHYSICAL FACTORS
1. PARTICLE SIZE
Smaller particle size, greater surface area then higher will be dissolution rate, because dissolution is thought to take place at the surface area of the solute( Drug). This study is imp. for drugs that have low aqueous solubility. Absorption of such drugs can be increased by increasing particle size by Micronization. ex. Griseofulvin, active intravenously but not effective when given orally.
08/10/2010 KLECOP, Nipani 75
1. PARTICLE SIZE
To poor soluble drug, disintegration agents and surface active agents may be added . ex. Bioavailability of Phenacetin is increased by tween 80. Micronization also reduces the dose of some drugs ex. the dose of griseofulvin is reduced to one half while the dose of spironolactone is reduced to one twentieth.
08/10/2010
KLECOP, Nipani
76
lesser effective
Finally drug size reduction and subsequent increase in surface area and dissolution rate is always not useful. Ex. of such drugs are Penicillin G & Erythromycin These Drugs are unstable and degrade quickly in solution.
Sometime, reduction in particle size of nitrofurantoin and piroxicam increase gastric irritation
These problem can be overcome by Microencapsulation.
08/10/2010
KLECOP, Nipani
78
2. Crystal Form
Substance can exist either in a crystalline or amorphous form. When substance exist in more than one crystalline form, the different form are called polymorphs and the phenomena as polymorphism . Two types of Polymorphism 1) Enantiotropic polymorph ex. Sulfur 2) Monotropic polymorph ex. Glyceryl Stearates Polymorphs have the same chemical structure but different physical properties such as solubility, density, hardness etc. ex. Chlormphenicol has a several crystal form, and when given orally as a suspension, the drug concentration in the body was found to be dependent on the percentage of - polymorph in the suspension. The form is more soluble and better absorbed.
08/10/2010 KLECOP, Nipani 79
One of the several form of polymorphic forms is more stable than other. Such a stable form having low energy state and high melting point and least aqueous solubility The remaining polymorphs are called as metastable forms which have high energy state, low melting point and high aqueous solubilities. About 40% of all organic compounds exhibit polymorphism. Some drug exists in amorphous form which have no internal crystal structure. Such drugs have high energy states than crystal form hence they have greater aqueous solubility than crystalline form. Ex. Novobiocin, cortisone acetate.
08/10/2010 KLECOP, Nipani 80
3. Solvates And Hydrates Many drugs associate with solvent and forms solvates Solvent is water then it is called as hydrate eg. Anhydrous form of caffeine and theophylline dissolve more rapidly than hydrous form of these drugs. Solvate form of drugs with org. solvent may dissolve fast in water than non solvated form. eg. Fluorocortisone 4. Complexation This property can influence the effective drug concentration in gi fluids. Complexation of drug and gi fluids may alter the rate and extent of absorption
eg. Intestinal Mucin form complex with Streptomycin and Dihydro Streptomycin. In some cases, Poor water soluble drugs can be administered as water soluble complexes. eg. Hydroquinone with Digoxin.
08/10/2010 KLECOP, Nipani 81
5.Adsorption
It is a physical and surface phenomena where the drug molecules are held on the surface of some inert substances by vanderwalls forces. ex. Charcoal used as an antidote; When it is co-administered with promazine, then it reduces the rate and extent of absorption Cholestyramine reduces the absorption of warfarin.
7. Salts Na or K salts of weak acid dissolves rapidly than free acid. ex. Na salts of Novobiocin shows improved bioavailability Certain salts also may have low solubility and dissolution rate.
8. Presence Of Surfactant
Use of wetting agent and Solubilizing agent improve the Dissolution rate & absorption of drugs. Ex. Tween 80 increase the rate & extent of absorption of Phenacetin. 9. Dissolution Disintegration is the formation of dispersed granules from an intact solid dosage form whereas the dissolution is the formation of solvated drug molecules from the drug
08/10/2010 KLECOP, Nipani 83
SOLID DRUG
DISSOLUTION
dc/dt = KS(CS-C) Where, dc/dt = Rate constant, K = constant, S = surface area of the dissolving solid, Cs=solubility of the drug in the solvent, C=concentration of drug in the solvent at time t. Constant K=D/h Where, D is the diffusion coefficient of the dissolving material and h is the thickness of the diffusion layer Here, C will always negligible compared to Cs So, dc/dt=DSCs/h
KLECOP, Nipani
08/10/2010
85
For a drug to be absorbed, it should be unionized and the unionized portion should be lipid soluble.
The fraction of drug remaining unionized is a function of both Dissociation constant (pKa) and pH of solution.
eg. Pivampicilin, the pivaloyloxy-methyl ester of ampicilin is More lipid soluble than ampicilin. Lipid solubility is provided to a drug by its partition coefficient between An organic solvent and water or an aq. Buffer (same pH of ab. Site) E.g. Barbital has a p.c. of 0.7 its absorption is 12% Phenobarbital ( p.c = 4.8 absorption=12%) Secobarbital (p.c =50.7 absorption=40%)
08/10/2010
KLECOP, Nipani
89
2)DRUG SOLUBILITY
The absorption of drug requires that molecule be in solution at absorption site. Dissolution, an important step, depends upon solubility of drug substance. pH solubility profile: pH environment of GIT varies from Acidic in stomach to slightly Alkaline in a small intestine.
Improvement of solubility:
Addition of acidic or basic excipient Ex: Solubility of Aspirin (weak acid) increased by addition of basic excipient. For formulation of CRD , buffering agents may be added to slow or modify the release rate of a fast dissolving drug.
08/10/2010
KLECOP, Nipani
91
PHARMACEUTICAL FACTORS
MEANS Absorption rate depends on the dosage Form which is administred,ingredients used, procedures Used in formulation of dosage forms.
The availability of the drug for absorption from the dosage forms is in order.
Solutions > Suspensions > capsules > Compressed Tablets > Coated tablets.
08/10/2010
KLECOP, Nipani
92
SOLUTIONS
Shows maximum bioavailability and factors affecting Absorption from solution are as follows
1. Chemical stability of drug 2. Complexation: between drug and exipients of formulation to increase the solubility, stability. 3. Solubilization: incorporation of drug into micelles to increase the solubility of drugs. 4. Viscosity 5. Type of solution: Whether aqueous or oily solution.
08/10/2010 KLECOP, Nipani 93
SUSPENSIONS: It comes next after solutions with respect to bioavailability Factors that affects absorption from suspensions are 1. Particle size and effective surface area of dispersed phase
2. Crystal form of drug: some drug can change their crystal structure. Eg. Sulfathiazole can change its polymorphic form, it can be overcome by addition by adding PVP. 3. Complexation: Formation of nonabsorbable complex between drug and other ingredients. Eg. Promazine forms a complex with attapulgite.
08/10/2010 KLECOP, Nipani 94
4. Inclusion of surfactant Eg. The absorption of phenacitin from suspension is increased in presence of tween 80. 5. Viscosity of suspension Eg. Methyl cellulose reduces the rate and absorption of nitrofurantoin 6. Inclusion of colourants: Eg. Brilliant blue in phenobarbitone suspension.
08/10/2010
KLECOP, Nipani
95
CAPSULES Two types of capsule 1. Hard gelatin capsule 2. Soft gelatin capsule
08/10/2010
KLECOP, Nipani
96
HARD GELATIN CAPSULE The rate of absorption of drugs from capsule is function Of some factors. 1.Dissolution rate of gelatin shell. 2.The rate of penetration of GI fluids into encapsulated mass 3.The rate at which the mass disaggregates in the GI fluid 4. The rate of dissolution. 5. Effect of excipients; a).Diluents b).Lubricants c). Wetting characteristics of drug d).Packing density
08/10/2010
KLECOP, Nipani
97
SOFT GELATIN CAPSULE SGS has a gelatin shell thicker than HGS,but shell is Plasticized by adding glycerin,sorbitol.SGS may used To contain non aqueous solution or liquid or semi solid. SGC have a better bioavailability than powder filled HGC And are equivalent to emulsions. Eg. Quinine derivative was better absorbed from SGC Containing drug base compared with HGC containing HCl salts. Grieseoflavin exhibited 88% absorption from soft gelatin Capsules compared to HGC(30%)
08/10/2010 KLECOP, Nipani 98
08/10/2010
KLECOP, Nipani
99
Compressed tablets Bioavailability are more due to large reduction in surface area.
A Intact tablets a K1 granules B
K2
Drug in GI fluid
K4
Drug absorbed in body
08/10/2010 KLECOP, Nipani 100
The overall dissolution rate and bioavailability of a poor Soluble drugs is influenced by 1.The physicochemical properties of liberated particles. 2. The nature and quantity of additives. 3. The compaction pressure and speed of compression. 4. The storage and age of tablet
08/10/2010
KLECOP, Nipani
101
1.Effect of diluents : Na Salicylates + starch = Faster dissolution Na salicylates + lactose=Poor dissolution. 2.Effect of Granulating agent: Phenobarbital + Gelatin solution=Faster dissolution Phenobarbital+PEG 6000= poor dissolution. 3.Effect of lubricants: Magnesium stearate will retard the dissolution of aspirin tablet Whereas SLS enhance the dissolution.
08/10/2010
KLECOP, Nipani
102
4.Effect of disintegrants: Starch tend to swell with wetting and break apart the dosage form. It is reported that 325mg of salicylic acid tablet were prepared by using different concentrations (5%,10%,20%) and max. dissolution was achieved With 20% starch.
5. Effect of colorants:
08/10/2010
KLECOP, Nipani
103
COATED TABLETS: There are three types of coating Sugar coating Film coating Enteric coating
SUGAR COATING: Sugar,Shellac,fatty glycerides, bees wax, silicone resin Sub coating agent: Talc,acacia,starch. FILM COATING: Polymers, dispersible cellulose derivatives like HPMC CMC. ENTERIC COATING: Shellac, cellulose acetate phthalate etc.
08/10/2010 KLECOP, Nipani 104
Factors affecting the drug release are 1.Thickness of coating e.g.. Quinine shows decrease in rate of absorption if coated with cellulose acetate phthalate. 2.The amount of dusting powder: 3.Effect of ageing: e.g. The shellac coated tablets of Para amino salicylic acid when given after two years plasma concentration of 6-7mg/100ml. However the tablets stored for 3 years showed plasma concentration of only 2mg/100ml which is the sub therapeutic effect.
08/10/2010 KLECOP, Nipani 105
SUBLINGUAL ROUTE: the dosage form is placed beneath the tongue. BUCCAL ROUTE: Dosage form is placed between the cheek and teeth or In the cheek pouch. Drugs administered by this route are supposed to produce systemic drug effects, and consequently, they must have good absorption from oral mucosa. Oral mucosal regions are highly vascularised therefore rapid onset of action is observed. For Eg, anti-anginal drug Nitroglycerin.
KLECOP, Nipani 106
08/10/2010
08/10/2010
KLECOP, Nipani
108
08/10/2010
KLECOP, Nipani
109
Factors to be considered:
Lipophilicity of drug: The lipid solubility should be high for absorption. 1. Salivary secretion: drug should be soluble in buccal fluid. 2. pH of saliva: pH of saliva is usually 6. 3. Storage compartment: some drugs have storage compartment in buccal mucosa. Eg, Buprenorphine 4. Thickness of oral epithelium: Sublingual absorption is faster than buccal, because former region is thinner than that of buccal mucosa.
08/10/2010
KLECOP, Nipani
110
Limited mucosal surface area. Taste of medicament and discomfort. EXAMPLES: Nitroglycerin, Isosorbide dinitrate, Progesterone, Oxytocin, Fenosterol, Morphine.
08/10/2010
KLECOP, Nipani
111
RECTAL ADMINISTRATION:
Absorption across the rectal mucosa occurs by passive diffusion. This route of administration is useful in children, old people and unconscious patients. Eg., drugs that administered are: aspirin, acetaminophen, theophylline, indomethacin, promethazine & certain barbiturates.
08/10/2010
KLECOP, Nipani
112
PARENTERAL ROUTES:
.
08/10/2010
KLECOP, Nipani
113
INTRAVENOUS ROUTE:
Absorption phase is bypassed (100% bioavailability) 1.Precise, accurate and almost immediate onset of action, 2. Large quantities can be given, fairly pain free 3. Greater risk of adverse effects a. High concentration attained rapidly b. Risk of embolism
08/10/2010 KLECOP, Nipani 114
INTRAVENOUS ROUTE:
This route is used when a rapid clinical response is required like treatment of epileptic seizures, acute asthmatic and cardiac arrhythmias. There may also be a danger of precipitation of drug in the vein if the inj. is too rapidly. This could result in thrombophlebitis. This mode of administration is required with drugs having short half lives and narrow therapeutic index. Bioavailability is not considered by this route. Mainly antibiotics are administered by this route.
KLECOP, Nipani 115
08/10/2010
In this route the drugs are injected directly into the artery. It is mainly used for cancer chemotherapy. It increased drug delivery to the area supplied by the infused artery and decreased drug delivery to systemic circulation.
08/10/2010
KLECOP, Nipani
116
Absorption of drug from muscles is rapid and absorption rate is perfusion rate limited. Polypeptides of less than approx 5000 gram per mole primarily pass through capillary pathway Greater than about 20000 g/mol are less able to traverse capillary wall, they primarily enter blood via lymphatic pathway.
08/10/2010
KLECOP, Nipani
117
08/10/2010
KLECOP, Nipani
118
SUBCUTANOUS ROUTE:
1. Slow and constant absorption 2. Absorption is limited by blood flow, affected if circulatory problems exist. 3. The blood supply to this is poorer than that of muscular tissue. 4. Concurrent administration of vasoconstrictor will slow absorption, e.g. Epinephrine. 5. The absorption is hastened by massage, application of heat to increase blood flow and inclusion of enzyme Hyaluronidase in drug solution. eg. Insulin.
08/10/2010 KLECOP, Nipani 119
08/10/2010
KLECOP, Nipani
120
TOPICAL ADMINISTRATION:
MUCOSAL MEMBRANES(eye drops, antiseptic, sunscreen, nasal, etc.) SKIN a. Dermal - rubbing in of oil or ointment (local action) b. Transdermal - absorption of drug through skin (systemic action) i. stable blood levels ii. no first pass metabolism iii. drug must be potent.
08/10/2010 KLECOP, Nipani 121
Skin consist of three layers : Epidermis Dermis Subcutaneous fat tissue The main route for the penetration of the drugs is generally through epidermal layer Stratum corneum is the rate limiting barrier in passive percutaneous absorption of drug.
08/10/2010
KLECOP, Nipani
122
The stratum corneum is the outermost layer of the epidermis and is composed mainly of dead keratinized cells (from lack of oxygen and nutrients). It has a thickness between 10 - 40 m. The dermis is the layer of skin beneath the epidermis. It contains the hair follicles, sweat glands, sebaceous glands, apocrine glands, lymphatic vessels and blood vessels. Hypodermis - Its purpose is to attach the skin to underlying bone and muscle as well as supplying it with blood vessels and nerves. The main cell types are fibroblasts, macrophages and adiposities (the hypodermis contains 50% of body fat).
08/10/2010
KLECOP, Nipani
123
08/10/2010
KLECOP, Nipani
124
OCULAR ADMINISTRATION
Eye is the most easily accessible site for topical administration of a medication. Topical application of drug to eyes meant for : Mydriasis, miosis, anaesthesia, treatment of infection, glaucoma etc. Opthalmic solution are administered into cul-de-sac. Barrier to intra occular penetration is cornea. It possess both hydrophilic and lipophilic characterstics. pH of lacrimal fluid is 7.4. pH of lacrimal fluid influences absorption of weak electrolyte like Pilocarpine.
KLECOP, Nipani 125
08/10/2010
OCULAR ADMINISTRATION
High pH of formulation: decrease tear flow and Low pH of formulation: increases tear flow. Human eye can hold around 10 microlitre of fluid. So small volume in concentrated form increases effectiveness. Viscosity empartners increases bioavailability eg, oily solutions, ointment etc. Systemic entry of drug occur by lacrimal duct which drains lacrimal fluid into nasal cavity.
KLECOP, Nipani 126
08/10/2010
Composition of eye
Water - 98% Solid -1.8% Organic element Protein - 0.67%, sugar - 0.65%, Nacl - 0.66% Other mineral element sodium, potassium and ammonia - 0.79%
08/10/2010
KLECOP, Nipani
127
08/10/2010
KLECOP, Nipani
128
Good corneal penetration. Prolong contact time with corneal tissue. Simplicity of instillation for the patient. Non irritative and comfortable form (viscous solution should not provoke lachrymal secretion and reflex blinking) Appropriate rheological properties concentrations of the viscous system.
KLECOP, Nipani 129
08/10/2010
Advantages
Increase ocular residence.. Improving bioavailability Prolonged drug release.. better efficacy Less visual & systemic side effects Increased shelf life Exclusion of preservatives Reduction of systemic side effects Reduction of the number of administration Better patient compliance Accurate dose in the eye. a better therapy
KLECOP, Nipani 130
08/10/2010
7.
8.
Drug release from dosage form Drug concentration in the formulation Drug oil water partition coefficient. Drug affinity to the skin tissue Surface area Site of application Hydration of skin Nature of vehicle used
KLECOP, Nipani 131
08/10/2010
08/10/2010
KLECOP, Nipani
132
INHALATIONAL ROUTE:
1.Gaseous and volatile agents and aerosols. 2.Rapid onset of action due to rapid access to circulation a.Large surface area b.Thin membranes separates alveoli from circulation c.High blood flow Particles larger than 20 micron and the particles impact in the mouth and throat. Smaller than 0.5 micron and they aren't retained.
08/10/2010
KLECOP, Nipani
133
Drugs generally administered by intra nasal route for treatment of local condition such as perennial rhinitis, allergic rhinitis and nasal decongestion etc. Absorption of lipophilic drugs through nasal mucosa by passive diffusion and absorption of polar drugs by pore transport. Rate of absorption of lipophilic drugs depend on their molecular weight. Drugs with molecular weight less than 400 daltons exhibit higher rate of absorption.
08/10/2010
KLECOP, Nipani
134
cont
Drugs with molecular weight 1000 daltons show moderate rate of absorption. Presently nasal route is becoming popular for systemic delivery of peptide and proteins, this is because of high permeability of nasal mucosa with vasculature.
08/10/2010
KLECOP, Nipani
135
08/10/2010
KLECOP, Nipani
136
Advantages
Rapid drug absorption via highly-vascularized mucosa Rapid onset of action Ease of administration, non-invasive Avoidance of the gastrointestinal tract and first-pass metabolism Improved bioavailability Lower dose/reduced side effects Improved convenience and compliance Self-administration.
KLECOP, Nipani 137
08/10/2010
Disadvantages
Nasal cavity provides smaller absorption surface area when compared to GIT. Relatively inconvenient to patients when compared to oral delivery since there is possibility of nasal irritation. The histological toxicity of absorption enhancers used in the nasal drug delivery system is not yet clearly established.
KLECOP, Nipani 138
08/10/2010
Enhancement in absorption
Following approaches used for absorption enhancement :Use of absorption enhancers Increase in residence time. Administration of drug in the form of microspheres. Use of physiological modifying agents
08/10/2010
KLECOP, Nipani
139
Enhancement in absorption
Absorption enhancers work by increasing the rate at which the drug pass through the nasal mucosa. Various enhancers used are surfactants, bile salts, chelaters, fatty acid salts, phospholipids, cyclodextrins, glycols etc.
08/10/2010
KLECOP, Nipani
140
Increased drug solubility Decreased mucosal viscosity Decrease enzymatic degradation Increased Paracellular transport Increased transcellular transport
KLECOP, Nipani 141
08/10/2010
Increase in residence time:By increasing the residence time the increase in the higher local drug concentration in the mucous lining of the nasal mucosa is obtained. Various mucoadhesive polymers like methylcellulose, carboxy methyl cellulose or polyarcylic acid are used for increasing the residence time.
KLECOP, Nipani 142
08/10/2010
Use of physiological modifying agents:These agents are vasoactive agents and exert their action by increasing the nasal blood flow. The example of such agents are histamine, leukotrienene D4, prostaglandin E1 and -adrenergic agents like isoprenaline and terbutaline.
KLECOP, Nipani 143
08/10/2010
Nasal delivery of organic based pharmaceuticals :Various organic based pharmaceuticals have been investigated for nasal delivery which includes drug with extensive presystemic metabolism. E.g. Progesterone, Estradiol, Nitroglycerin, Propranolol, etc.
08/10/2010
KLECOP, Nipani
144
Nasal delivery of peptide based drugs :Nasal delivery of peptides and proteins is depend on The structure and size of the molecule. Nasal residence time Formulation variables (pH, viscosity)
08/10/2010
PULMONARY ADMINISTRATION The drugs may be administered for local action of bronchioles or their systemic effects through absorption of lungs. Inhalation sprays and aerosols are used to deliver the drugs to the lungs. Larger surface area of alveoli, high permeability of alveolar epithelium for drug penetration, and a rich vasculature are responsible for rapid absorption of drugs by this route
KLECOP, Nipani 146
08/10/2010
PULMONARY ADMINISTRATION
In general particles greater than 10mm are retained in the throat and upper airways whereas fine particles reach the pulmonary epithelium Drugs generally administered by this route are bronchodilators (e.g.. Salbutamol, isoproterenol), antiallergic (e.g.. Cromolym sodium), and antiinflammatory (e.g.. Betamethasone, dexamethasone).
08/10/2010 KLECOP, Nipani 147
08/10/2010
KLECOP, Nipani
148
Advantages
Reduce the potential incidence of adverse systemic effect. It used when a drug is poorly absorbed orally, e.g. Na cromoglicate. It is used when drug is rapidly metabolized orally, e.g. isoprenaline
KLECOP, Nipani 149
08/10/2010
IN-VITRO METHODS
Everted small intestine sac method. Everted sac modification. Circulation technique. Everted intestinal ring or slice technique.
KLECOP, Nipani 150
08/10/2010
Because of economical & ethical limitations of in-vivo studies. Simple & provide valuable information. To assess the major factors involved in absorption. Predict the rate & extent of drug absorption. Procedures are of great value during screening of new drug candidates. Carried out outside the body. Used to assess permeability of drug using animal tissues.
KLECOP, Nipani 151
08/10/2010
Contd
152
Flask & its contents oxygenated & agitated at 37oC for specific period of time
08/10/2010
KLECOP, Nipani
153
Advantages
Prolongs the viability & integrity of the preparation after removal from the animal. Convenience & accuracy with respect to drug analysis. The epithelial cells of the mucosal surface are exposed directly to the oxygenated mucosal fluid.
Crane & Wilson modification. Essential features of simple sac methods are retained. Modification- the intestine is tied to a cannula.
KLECOP, Nipani 156
08/10/2010
Water maintained at aerator 37o C 08/10/2010 KLECOP, Nipani (FIG: EVERTED SAC MODIFICATION)
157
Procedure
Animal fasted for 20-24hrs
Animal killed with blow on head or anesthetized with ether or chloroform Entire small intestine is everted
08/10/2010 KLECOP, Nipani 158
Contd
Segments of 5-15cm length are cut from specific region of the intestine
About 1ml/5cm length of drug free buffer is then placed in serosal compartment
The entire volume of serosal solution is removed from the sac at each time interval with the help of syringe & it is replaced with fresh buffer solution. The amount of drug that permeates the intestinal mucosa is plotted against time to describe the absorption profile of the drug at any specific pH.
KLECOP, Nipani 160
08/10/2010
Advantages
A number of different solutions may be tested with a single segment of the intestine unlike in the sac technique. Simple & reproducible. It distinguishes between active & passive absorption. It determines the region of the small intestine where absorption is optimal, particularly in the case of active transport. Also used to study the effect of pH, surface active agents, complexation & enzymatic reaction.
KLECOP, Nipani 161
08/10/2010
Disadvantages
The intestinal preparation is removed from the animal as well as from its blood supply. Under these conditions, the permeability characteristics of the membrane are significantly altered. The rate of transport of drug as determined from the everted sac technique, may be slower than in the intact animal.
KLECOP, Nipani 162
08/10/2010
Circulation technique
Small intestine may or may not be everted. In this method either entire small intestine of small lab animal or a segment is isolated. Oxygenated buffer containing the drug is circulated through the lumen. Drug free buffer is also circulated on the serosal side of the intestinal membrane & oxygenated. Absorption rate from the lumen to the outer solution are determined by sampling both the fluid circulating through the lumen.
KLECOP, Nipani 163
08/10/2010
Advantages
This is applicable to kinetic studies of the factors affecting drug absorption. Both surface are oxygenated. Eversion is not necessary.
08/10/2010
KLECOP, Nipani
164
Intestine cut wit scalpel or scissors into ring like slices, 0.1-0.5cm length
Intestine washed with buffer & dried by blotting with filter paper
Dried rings transferred to stoppered flask containing buffer with drug at 37oC
08/10/2010 KLECOP, Nipani
Contd165
At selected time intervals, the tissues slices are assayed for drug content
08/10/2010
KLECOP, Nipani
166
Advantages
MAJOR DISADVANTAGE OF IN-VITRO METHODS is that the are based on approximation & oversimplification of the actual in-vivo conditions.
08/10/2010 KLECOP, Nipani 167
In-situ methods
08/10/2010
In this method the animals blood supply remains intact & thus the results of rate of absorption determined may be more realistic than those from in-vitro techniques. Alternative means to in-vivo models in evaluating the relative contribution of GI absorption to oral bioavailability. Act as bridge between in-vitro & in-vivo methods. Mimic the in-vivo physiological process with significant reduction in cost & time.
KLECOP, Nipani 169
08/10/2010
Contd
170
Replacement of intestine.
Incision closed & duodenal cannula is attached to an infusion pump Intestine cleared off particulate matter using drug free buffer (1.5ml/30min)
Contd
171
Relative rate of absorption calculated Relative rate of absorption = difference in the drug concentration entering & leaving the intestine
08/10/2010 KLECOP, Nipani 172
Figure
08/10/2010
KLECOP, Nipani
173
Here, single or multiple intestinal loops are used for studying absorption Adult male rat fasted & water with held for 1-2hrs before expt. Under anesthesia an abdominal incision is made & small intestine exposed. Placement of proximal ligature & distal ligature.
Contd..
For preparing multiple loops, the procedure is identical to single loop preparation with a distance of approximately one half inch left between successive loops.
Advantages
Lumen washed several times with saline & subsequently with 0.1N HCl containing 0.15M NaCl
Contd.
177
After 1hr, the drug solution is removed from the gastric pouch & assayed for drug content.
In-situ techniques equate absorption with loss of drug from the GI lumen & if a drug is significantly accumulated or metabolized in gut wall, one will get an overestimate of the amount of drug absorbed
08/10/2010 KLECOP, Nipani 178
In-vivo methods
Direct method.
Indirect method.
08/10/2010
KLECOP, Nipani
179
Only method to assess the importance of many factors likeGastric emptying. Intestinal motility. Effect of drug on GIT.
The influence of dosage form variables on drug absorption can also be studied.
KLECOP, Nipani 180
08/10/2010
Direct method
The drug level in blood or urine is determined as a function of time. Absorption studies on experimental animals & clinical trials. Selection of experimental animals- pigs, dogs, rabbits, rat.
KLECOP, Nipani 181
08/10/2010
Procedure
A blank urine or blood sample is taken for the test animal before the experiment.
Assay for drug content & determination of rate & extent of drug absorption.
08/10/2010 KLECOP, Nipani 182
Indirect method
Adopted when the measurement of drug concentration in blood or urine is difficult or not possible. Pharmacological response is taken as the index of drug absorption. LD 50 appears to be dependent on the rate of absorption of drug & hence on the rate of dissolution. A plot of log dose vs. duration of response time is plotted.
KLECOP, Nipani 183
08/10/2010
Log dose
Fka/2.303
x
Duration of response time
Where,
F= bioavailability. Ka= the absorption rate constant. d= threshold dose
08/10/2010 KLECOP, Nipani 184
REFERENCES
1. Biopharmaceutics & pharmacokinetics by D.M.Brahmankar & Sunil B. Jaiswal. 2. Biopharmaceutics & pharmacokinetics by P.L.Madan. 3. Biopharmaceutics & pharmacokinetics by G.R.Chatwal. 4. Human anatomy & physiology by Tortora. 5. www.google.com.
08/10/2010
KLECOP, Nipani
185
Thank you
Cell No: 00919742431000 E-mail: bknanjwade@yahoo.co.in
08/10/2010
KLECOP, Nipani
186